Diagnostic Tests and Genetic Interpretation

Confirming a diagnosis of KCNMA1-associated Generalized epilepsy-paroxysmal dyskinesia (GEPD) requires a multi-step process that looks at both your child’s genetic code and how their brain behaves in real-time. Because the condition involves two very different types of “attacks,” standard tests must be used in specific ways to get a clear picture.

The Gold Standard: Synchronized Video-EEG

While a regular EEG can show “spikes” or “waves” that suggest a risk for seizures, it cannot always tell you if a specific movement is a seizure or a non-epileptic movement attack ^[1][2].

The Synchronized Video-EEG is a highly useful standard test for this condition ^[3]. During this test, a video camera records your child’s physical movements while electrodes record their brain’s electrical activity at the exact same time ^[4].

• Why it matters: In KCNMA1, many movement attacks (dyskinesia) can look exactly like seizures, including behavioral arrest (freezing) and falling ^[1].
• The Result: If the video shows a movement but the EEG shows no change in brain waves, this supports, but does not definitively prove, a non-epileptic event, as scalp EEGs can miss deep seizures or be obscured by artifact ^[3]. If the EEG shows a “spike-wave” pattern during the movement, it supports an epileptic seizure (though interictal spikes can occasionally coincide with non-epileptic movements) ^[1][4].

Capturing a “habitual” event—the type of episode you see most often at home—is highly useful for specialists to classify the event ^[4].

Imaging: Brain MRI

A Brain MRI is a test for structural contributors to the condition. In KCNMA1, the imaging findings are variable ^[2].

• Gain-of-Function (GoF): In children with the GEPD/PNKD3 subtype, the brain MRI is often entirely normal ^[5]. A normal MRI does not mean your child is not experiencing significant symptoms.
• Loss-of-Function (LoF): In contrast, LoF variants are more frequently associated with structural changes. These may include cerebellar atrophy (shrinking of the balance center), cerebral atrophy, or rare cortical malformations like polymicrogyria ^[6][7][8].
• MRI cannot establish the channel mechanism; interpreted by a neuroradiologist, it helps assess for structural abnormalities rather than classifying KCNMA1 function.

Genetic Testing Requirements

Because KCNMA1 is a rare and specific gene, it is often missed by basic genetic screenings. Depending on the clinical situation, it may be found through an Epilepsy or Movement Disorder panel, or Whole Exome Sequencing (WES)/Whole Genome Sequencing (WGS) ^[9][10].

Completeness Checklist for Your Genetic Report

A high-quality genetic report should contain specific details that help your doctors tailor your child’s care. Check your report for these four key elements:

1. The Specific Gene and Variant: It should clearly name KCNMA1 and the exact “address” of the mutation (e.g., p.Asn999Ser or N999S) ^[5][11].
2. Zygosity: This indicates if the child has one copy of the mutation (heterozygous) or two copies (homozygous) ^[6][5]. Most GEPD cases are heterozygous.
3. Inheritance (Trio Testing): The report should state if the variant is de novo (a new change in the child) or inherited from a parent ^[10][12]. This is essential for understanding the risk for future siblings. Even with a de novo result, possible mosaicism means a low but non-zero recurrence risk.
4. Functional Classification: While not always present on the initial report, the clinical team must determine if the variant is Gain-of-Function (linked to movement attacks and seizures) or Loss-of-Function (linked to developmental delays and structural brain changes) ^[5][11].

If your report lists a Variant of Uncertain Significance (VUS), it means the lab has found a change but isn’t yet sure if it causes disease ^[13]. A VUS should not be used as proof of the diagnosis, to guide predictive testing, or to drive variant-specific treatment. In these cases, re-evaluating the data is recommended as scientific knowledge about KCNMA1 grows; reanalysis intervals depend on the laboratory ^[13].